Back to results
US 11,628,214 B2Granted
Immunogenic compositions and vaccines comprising African swine fever virus peptides and proteins and uses thereof
OwnerVeljko Nikolin, Egbert Siegfried Mundt +3inventors
InventorsVeljko Nikolin, Egbert Siegfried Mundt, Fernando Rodriguez Gonzalez, Laia Bosch Camos, Javier Alonso Collado Miguens
Life of this patent
Estimating the term…
Abstract
The present invention relates to African swine fever virus (ASFV) peptides and/or polypeptides as well as immunogenic fragments thereof, corresponding encoding AFSV oligonucleotides and/or polynucleotides as well as immunogenic fragments thereof, immunogenic compositions, vaccines and uses thereof.
Claims9
An immunogenic composition comprising
- (a) an African swine fever virus (ASFV) polypeptide MGF100-1L, wherein the MGF100-1L polypeptide is selected from amino acid sequences which are at least 95% identical to an amino acid sequence selected from the group of:
- (SEQ ID NOS:
- 572, 570);
- or
- (b) a heterologous viral or bacterial vector comprising African swine fever virus oligonucleotides encoding African swine fever virus polypeptide MGF100-1L, wherein the MGF100-1L polypeptide is selected from amino acid sequences which are at least 95% identical to an amino acid sequence selected from the group consisting of:
- (SEQ ID NOS:
- 572, 570);
- and
- (c) one or more pharmaceutical- or veterinary-acceptable carriers or excipients;
- and
- (d) an adjuvant.
8 more elements
Dependencies are inferred from the claim text.